meRfi®-GM
Insulin-like growth factor 1 (IGF-1)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Gut dysbiosis caused a reduction in Insulin-like growth factor 1 (IGF-1) expression in mLN tissue and induced hyperreactivity of RA signaling and IFN-I response in mLN.
The IGF-1/Akt pathway inhibits RA signaling and the IFN-I response, which positively affects CD4+ Th2 cells differentiation.
In ov…
References (Sources)
- Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population
- Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality
- Nutrition, longevity and disease: From molecular mechanisms to interventions
- Short-Chain Fatty Acids Calibrate RARa Activity Regulating Food Sensitization
- Somatotropic signaling: trade-offs between growth, reproductive development, and longevity
- The possible role of insulin-like growth factor-1 in osteosarcoma